222 related articles for article (PubMed ID: 36830291)
1.
Herrera S; Morata L; Sempere A; Verdejo M; Del Rio A; Martínez JA; Cuervo G; Hernández-Meneses M; Chumbita M; Pitart C; Puerta P; Monzó P; Lopera C; Aiello F; Mendoza S; Garcia-Vidal C; Soriano A; Bodro M
Antibiotics (Basel); 2023 Feb; 12(2):. PubMed ID: 36830291
[TBL] [Abstract][Full Text] [Related]
2. Pseudomonas aeruginosa bloodstream infections in children and adolescents: risk factors associated with carbapenem resistance and mortality.
Rodríguez NEG; Aguilera-Alonso D; Escosa L; Gómez-Gil MR; Manzanares Á; Ascaso MG; Bermejo-Gómez A; Abad MJG; Ramos AM; Núñez AS; Orellana MÁ; Cercenado E; Lozano JS; Calvo C; Baquero-Artigao F;
J Hosp Infect; 2024 May; 149():56-64. PubMed ID: 38735628
[TBL] [Abstract][Full Text] [Related]
3. Bloodstream infections after solid organ transplantation: clinical epidemiology and antimicrobial resistance (2016-21).
Adelman MW; Connor AA; Hsu E; Saharia A; Mobley CM; Victor DW; Hobeika MJ; Lin J; Grimes KA; Ramos E; Pedroza C; Brombosz EW; Ghobrial RM; Arias CA
JAC Antimicrob Resist; 2024 Feb; 6(1):dlad158. PubMed ID: 38213312
[TBL] [Abstract][Full Text] [Related]
4. Risk factors and predictors of carbapenem-resistant
Papadimitriou-Olivgeris M; Fligou F; Spiliopoulou A; Koutsileou K; Kolonitsiou F; Spyropoulou A; Zotou A; Marangos M; Anastassiou ED; Christofidou M; Spiliopoulou I
J Med Microbiol; 2017 Aug; 66(8):1092-1101. PubMed ID: 28758623
[No Abstract] [Full Text] [Related]
5. Socioeconomic burden of bloodstream infections caused by carbapenem-resistant and carbapenem-susceptible Pseudomonas aeruginosa in China.
Yang K; Xiao T; Shi Q; Zhu Y; Ye J; Zhou Y; Xiao Y
J Glob Antimicrob Resist; 2021 Sep; 26():101-107. PubMed ID: 34023532
[TBL] [Abstract][Full Text] [Related]
6. High Rate of Inappropriate Antibiotics in Patients with Hematologic Malignancies and Pseudomonas aeruginosa Bacteremia following International Guideline Recommendations.
Chumbita M; Puerta-Alcalde P; Yáñez L; Angeles Cuesta M; Chinea A; Español-Morales I; Fernandez-Abellán P; Gudiol C; González-Sierra P; Rojas R; Sánchez-Pina JM; Vadillo IS; Sánchez M; Varela R; Vázquez L; Guerreiro M; Monzo P; Lopera C; Aiello TF; Peyrony O; Soriano A; Garcia-Vidal C
Microbiol Spectr; 2023 Aug; 11(4):e0067423. PubMed ID: 37367629
[TBL] [Abstract][Full Text] [Related]
7. Risk factors and mortality of carbapenem-resistant Klebsiella pneumoniae bloodstream infection in a tertiary-care hospital in China: an eight-year retrospective study.
Chen J; Ma H; Huang X; Cui Y; Peng W; Zhu F; Ma S; Rao M; Zhang P; Yang H; Su L; Niu R; Pan P
Antimicrob Resist Infect Control; 2022 Dec; 11(1):161. PubMed ID: 36536423
[TBL] [Abstract][Full Text] [Related]
8. Clinical Outcomes and Risk Factors for Carbapenem-resistant Enterobacterales Bloodstream Infection in Solid Organ Transplant Recipients.
Anesi JA; Lautenbach E; Thom KA; Tamma PD; Blumberg EA; Alby K; Bilker WB; Werzen A; Ammazzalorso A; Tolomeo P; Omorogbe J; Pineles L; Han JH
Transplantation; 2023 Jan; 107(1):254-263. PubMed ID: 35856636
[TBL] [Abstract][Full Text] [Related]
9. Risk Factors for Infection and Mortality Associated With Stenotrophomonas maltophilia Bloodstream Infections in Children; Comparison With Pseudomonas aeruginosa Bloodstream Infections.
Bilen NM; Sahbudak Bal Z; Güner Özenen G; Yildirim Arslan S; Ozek G; Ozdemir Karadas N; Yazici P; Cilli F; Kurugöl Z
Pediatr Infect Dis J; 2023 May; 42(5):374-380. PubMed ID: 36795557
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and Outcomes of Carbapenem-resistant Bloodstream Infection in Children With Cancer.
Nirmal G; Jithin TK; Gopakumar KG; Parthiban R; Nair C
J Pediatr Hematol Oncol; 2023 Aug; 45(6):e678-e682. PubMed ID: 37146155
[TBL] [Abstract][Full Text] [Related]
11. Risk factors and outcomes of bacteremia caused by drug-resistant ESKAPE pathogens in solid-organ transplant recipients.
Bodro M; Sabé N; Tubau F; Lladó L; Baliellas C; Roca J; Cruzado JM; Carratalà J
Transplantation; 2013 Nov; 96(9):843-9. PubMed ID: 23883973
[TBL] [Abstract][Full Text] [Related]
12. Risk Factors and Outcomes of Antibiotic-resistant Pseudomonas aeruginosa Bloodstream Infection in Adult Patients With Acute Leukemia.
Zhao Y; Lin Q; Liu L; Ma R; Chen J; Shen Y; Zhu G; Jiang E; Mi Y; Han M; Wang J; Feng S
Clin Infect Dis; 2020 Dec; 71(Suppl 4):S386-S393. PubMed ID: 33367574
[TBL] [Abstract][Full Text] [Related]
13. A retrospective analysis of
Shi Q; Huang C; Xiao T; Wu Z; Xiao Y
Antimicrob Resist Infect Control; 2019; 8():68. PubMed ID: 31057792
[TBL] [Abstract][Full Text] [Related]
14. Incidence, antimicrobial resistance and mortality of
Xiao S; Liang X; Han L; Zhao S
Front Public Health; 2023; 11():1294141. PubMed ID: 38249405
[TBL] [Abstract][Full Text] [Related]
15. Rates, predictors and mortality of community-onset bloodstream infections due to Pseudomonas aeruginosa: systematic review and meta-analysis.
Rojas A; Palacios-Baena ZR; López-Cortés LE; Rodríguez-Baño J
Clin Microbiol Infect; 2019 Aug; 25(8):964-970. PubMed ID: 30995530
[TBL] [Abstract][Full Text] [Related]
16. Factors influencing mortality in solid organ transplant recipients with bloodstream infection.
Oriol I; Sabé N; Melilli E; Lladó L; González-Costello J; Soldevila L; Carratalà J
Clin Microbiol Infect; 2015 Dec; 21(12):1104.e9-14. PubMed ID: 26253289
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the systemic inflammatory response syndrome between monomicrobial and polymicrobial Pseudomonas aeruginosa nosocomial bloodstream infections.
Marra AR; Bearman GM; Wenzel RP; Edmond MB
BMC Infect Dis; 2005 Oct; 5():94. PubMed ID: 16259623
[TBL] [Abstract][Full Text] [Related]
18. Extensively drug-resistant Pseudomonas aeruginosa bacteremia in solid organ transplant recipients.
Bodro M; Sabé N; Tubau F; Lladó L; Baliellas C; González-Costello J; Cruzado JM; Carratalà J
Transplantation; 2015 Mar; 99(3):616-22. PubMed ID: 25119130
[TBL] [Abstract][Full Text] [Related]
19. Risk factors and outcomes of inpatients with carbapenem-resistant
Yuan Q; Guo L; Li B; Zhang S; Feng H; Zhang Y; Yu M; Hu H; Chen H; Yang Q; Qu T
Front Microbiol; 2023; 14():1137811. PubMed ID: 37260693
[TBL] [Abstract][Full Text] [Related]
20. Real-Life Use of Ceftolozane/Tazobactam for the Treatment of Bloodstream Infection Due to Pseudomonas aeruginosa in Neutropenic Hematologic Patients: a Matched Control Study (ZENITH Study).
Bergas A; Albasanz-Puig A; Fernández-Cruz A; Machado M; Novo A; van Duin D; Garcia-Vidal C; Hakki M; Ruiz-Camps I; Del Pozo JL; Oltolini C; DeVoe C; Drgona L; Gasch O; Mikulska M; Martín-Dávila P; Peghin M; Vázquez L; Laporte-Amargós J; Durà-Miralles X; Pallarès N; González-Barca E; Álvarez-Uría A; Puerta-Alcalde P; Aguilar-Company J; Carmona-Torre F; Clerici TD; Doernberg SB; Petrikova L; Capilla S; Magnasco L; Fortún J; Castaldo N; Carratalà J; Gudiol C
Microbiol Spectr; 2022 Jun; 10(3):e0229221. PubMed ID: 35475683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
